Semler Scientific Inc (OTCMKTS:SMLR) Director Sells $107,025.00 in Stock

Semler Scientific Inc (OTCMKTS:SMLR) Director Wayne T. Pan sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $42.81, for a total transaction of $107,025.00.

Shares of OTCMKTS SMLR traded down $0.18 during mid-day trading on Thursday, hitting $42.81. 21,259 shares of the stock traded hands, compared to its average volume of 15,972. Semler Scientific Inc has a twelve month low of $28.53 and a twelve month high of $54.50. The company has a market cap of $289.88 million, a PE ratio of 64.86, a price-to-earnings-growth ratio of 1.46 and a beta of 0.34. The firm has a 50 day simple moving average of $44.57 and a two-hundred day simple moving average of $44.66.

Semler Scientific (OTCMKTS:SMLR) last issued its earnings results on Wednesday, October 30th. The medical equipment provider reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.09. Semler Scientific had a return on equity of 116.92% and a net margin of 46.11%. The business had revenue of $8.90 million during the quarter, compared to analysts’ expectations of $8.09 million. On average, equities analysts anticipate that Semler Scientific Inc will post 1.18 EPS for the current year.

Separately, ValuEngine downgraded shares of Semler Scientific from a “hold” rating to a “sell” rating in a report on Thursday, November 14th.

Semler Scientific Company Profile

Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Article: Book Value Per Share – BVPS

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.